大环内酯类抗生素在慢性呼吸道疾病中的抗炎作用及应用价值
被引量：2
摘要
本文介绍了大环内酯类抗生素在慢性呼吸道疾病中的作用机制及使用价值。
出处
《实用心脑肺血管病杂志》
2005年第4期250-251,共2页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
参考文献13
-
1Takizawa H,Desaki T,Ohtoshi T,et al.Erythromycin andclarithromycin attenuate cytokine-induced endothelin-lexpression in human bronchial epithelial cells.Eur Respir J.1998,12:57～63.
-
2Desaki M,Takizawa H,Ohtoshi T,et al.Erythromycin suppress nuclear factor-kappa B and activator protein-1 activator protein-1 activation in human bronchial epithelial cells.Biochem Biophys res Commun.2000,267:124～128.
-
3Abe S,Nakamura H,Inoue S,et al.Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells.Am J Respir Cell Mol Biol.2000,22:51～60.
-
4Khari OA,Devalia JL,Abdelazia MM,et al.Effect of erythromycin on haemophilus influeniae endotoxin-induced released of IL-6/IL-8 and sicam-1 by cultured human bronchial epithelial cells.Europen Respir J.1995,8:1451～1457.
-
5Sakito O,Kadota J,Kohno S,et al.Interleukin 1 beta,tumor necrosis factor alpha,and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis:a potential mechanism of macrolide therapy.Respiration.1996,63:42～48.
-
6Schultz MJ,Speelman P,Hack CE,et al.Intravenous infusion of erythromycin inhibits CXC chemokine production,but aguement neutrophil degranulation in whole blood stimulated with streptococcus pneumonia.J Antimicrob Chemother.2000,46:235～240.
-
7Sato E,Nelson DK,Koyama S,et al.Erythromycin modulates eosinphil chemotactic cytokines production by human lung fibroblasts in vitro.Antimicrob Agents Chemother.2001,45:401～406.
-
8Anderson R.Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattranctant actived superoxide generation and autooxidation.J Infect Dis.1989,5:966～972.
-
9Sugihara E,Koyanagi T,et al.Macrolide antibiotics directly reduce active oxygen generation by neutrophils in human peripheral blood.Jurume Med J.2003,50:9～15.
-
10Theron AJ,Feldman C,Anderson R.Investigation of the anti inflammatory and membrane stabilizing potential of spiramycin in vitro.J Antimicrob Chemother.2000,46:269～271.
同被引文献28
-
1程书权,段刚.红霉素及其衍生物在呼吸系非感染疾病中的若干应用探索[J].国外医学（呼吸系统分册）,2004,24(6):356-359. 被引量：9
-
2路苓,汤晓梅.儿童应用阿奇霉素发生不良反应的因素及干预方法[J].山东医药,2005,45(34):22-22. 被引量：1
-
3罗蓉,黄英.重庆地区小儿肺炎下呼吸道分泌物病原耐药性分析[J].实用儿科临床杂志,2006,21(4):224-225. 被引量：18
-
4薛光运.阿奇霉素两种方案治疗下呼吸道感染疗效及药物经济学比较[J].山东医药,2006,46(16):79-79. 被引量：3
-
5李松坤,陈枫.头孢哌酮联合阿奇霉素治疗呼吸道细菌感染临床观察[J].黑龙江医学,2007,31(11):858-859. 被引量：2
-
6Daniel Sevilla-Sánchez,Dolors Soy-Muner,Néstor Soler-Porcar.Usefulness of Macrolides as Anti-inflammatories in Respiratory Diseases[J].Archivos de Bronconeumología (Internet).2010(5)
-
7Yoshitomo Morinaga,Katsunori Yanagihara,Naoyuki Miyashita,Masafumi Seki,Koichi Izumikawa,Hiroshi Kakeya,Yoshihiro Yamamoto,Hiroshi Mukae,Yasuaki Yamada,Shigeru Kohno,Shimeru Kamihira.Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells[J].Pulmonary Pharmacology & Therapeutics.2009(6)
-
8Bo?ka Hrva?i?,Berislav Bo?njak,Martina Bosnar,?eljko Feren?i?,Ines Glojnari?,Vesna Erakovi? Haber.Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma[J].European Journal of Pharmacology.2009(1)
-
9Antonio Anzueto,Sandra Norris.Clarithromycin in 2003: sustained efficacy and safety in an era of rising antibiotic resistance[J].International Journal of Antimicrobial Agents.2004(1)
-
10Miyanohara T,Ushikai M,Matsune S,Ueno K,Katahira S,Kurono Y.Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts[].Laryngoscope.2000
二级引证文献6
-
1田晓华.左氧氟沙星不良反应及其临床处理对策[J].临床合理用药杂志,2020,13(5):119-120. 被引量：4
-
2薛海霞,杨卫丽.阿奇霉素与β-内酰胺类抗菌药物联合应用情况调查[J].临床合理用药杂志,2015,8(20):90-91. 被引量：2
-
3张健明.大环内酯类抗生素的抗炎作用及其在呼吸道疾病中的应用[J].现代诊断与治疗,2015,26(8):1774-1775. 被引量：3
-
4杨成.加味当归四逆汤治疗膝关节骨性关节炎疗效观察[J].临床合理用药杂志,2017,10(16):109-110. 被引量：3
-
5贵磊,陈平,覃健杰.大环内酯类抗生素对慢性阻塞性肺疾病研究进展[J].大众科技,2018,20(12):50-53. 被引量：2
-
6吕春卉.阿奇霉素治疗呼吸系统感染的药理作用及临床应用观察[J].智慧健康,2019,0(21):82-83. 被引量：1
-
1柏建南,郑杨.高压氧在冠心病治疗中的作用及应用价值[J].吉林医学,2011,32(4):758-760. 被引量：9
-
2江明芳,张家美.阿托伐他汀钙预防造影剂肾病的研究进展[J].安徽医药,2016,20(1):9-13. 被引量：8
-
3张敏,浦钧宗,朱全.预处理的心肌保护作用及应用前景[J].中国运动医学杂志,2000,19(1):74-76. 被引量：13
-
4梁小华,王宁,马维维.高压氧在冠心病治疗中的作用及应用价值[J].四川医学,2012,33(11):1989-1991. 被引量：5
-
5邓莎,秦大莲.AT_1受体拮抗剂作用及应用研究进展[J].泸州医学院学报,2008,31(4):467-469. 被引量：2
-
6杜柯君,刘元明,胡德成,陈永宏.机械通气在重度有机磷中毒致呼吸衰竭中的临床应用[J].临床医学,2006,26(5):31-32. 被引量：2
-
7苏华田.机械通气在重度有机磷中毒致呼吸衰竭的临床应用[J].中国社区医师（医学专业）,2009,11(5):40-40. 被引量：1
-
8张琍.表皮生长因子及其受体对胃肠道的作用及应用前景[J].湖南医学,1996,13(5):300-301.
-
9李春艳.简析钙拮抗剂在3类心血管疾病中的作用及应用[J].中国医药指南,2011,9(14):204-204. 被引量：4
-
10高亚东,熊盛道,徐永健.钾通道与支气管哮喘[J].国外医学（内科学分册）,2003,30(9):392-395.
